1.           Introduction

1.1         Study Scope

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        North America Human Papillomavirus (HPV) Vaccines Market – By Type

1.3.2        North America Human Papillomavirus (HPV) Vaccines Market – By Dosage

1.3.3        North America Human Papillomavirus (HPV) Vaccines Market – By Age

1.3.4        North America Human Papillomavirus (HPV) Vaccines Market – By Application

1.3.5        North America Human Papillomavirus (HPV) Vaccines Market – By Distribution Channel

1.3.6        North America Human Papillomavirus (HPV) Vaccines Market – By Country

2.           Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           North America Human Papillomavirus (HPV) Vaccine Market – Market Landscape

4.1         Overview

4.2         North America PEST Analysis

4.3         Experts Opinion

5.           North America Human Papillomavirus (HPV) Vaccine Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Increase in Prevalence of HPV Associated Diseases

5.1.2        Initiatives Taken by Health Organizations

5.2         Market Restraints

5.2.1        High Cost of HPV Vaccines

5.3         Market Opportunities

5.3.1        Growing Number of HPV Awareness Programs

5.4         Future Trends

5.4.1        Advancements in HPV Diagnostics Tests

5.5         Impact Analysis

6.           Human Papillomavirus (HPV) Vaccine Market– North America Analysis

6.1         North America Human Papillomavirus (HPV) Vaccine Market Revenue Forecast and Analysis

7.           North America Human Papillomavirus (HPV) Vaccine Market Analysis – By Type

7.1         Overview

7.2         By Type: Market Revenue and Forecast Analysis (US$ Million)

7.3         9-valent HPV vaccine

7.3.1        Overview

7.3.2        9-valent HPV vaccine Market Revenue and Forecast to 2028 (US$ Million)

7.4         Quadrivalent HPV vaccine

7.4.1        Overview

7.4.2        Quadrivalent HPV vaccine Market Revenue and Forecast to 2028 (US$ Million)

7.5         Bivalent HPV Vaccine

7.5.1        Overview

7.5.2        Bivalent HPV Vaccine Market Revenue and Forecast to 2028 (US$ Million)

8.           North America Human Papillomavirus (HPV) Vaccine Market Analysis - By Dosage

8.1         North America Human Papillomavirus (HPV) Vaccine Market Revenue Share, by Dosage (2022 and 2028)

8.2         2 Dose

8.2.1        Overview

8.2.2        2 Dose: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

8.3         3 Dose

8.3.1        Overview

8.3.2        3 Dose: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

9.           North America Human Papillomavirus (HPV) Vaccine Market Analysis - By Age

9.1         North America Human Papillomavirus (HPV) Vaccine Market Revenue Share, by Age (2022 and 2028)

9.2         9 to 14 Years

9.2.1        Overview

9.2.2        9 to 14 Years: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

9.3 to 45 Years

9.3.1        Overview

9.3.2 to 45 Years: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

10.        North America Human Papillomavirus (HPV) Vaccine Market Analysis - By Application

10.1      North America Human Papillomavirus (HPV) Vaccine Market Revenue Share, by Application (2022 and 2028)

10.2      HPV-attributable Cancer

10.2.1     Overview

10.2.2     HPV-attributable Cancer: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

10.3      Genital Warts

10.3.1     Overview

10.3.2     Genital Warts: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

11.        North America Human Papillomavirus (HPV) Vaccine Market Analysis – By End User

11.1      Overview

11.2      North America Human Papillomavirus (HPV) Vaccine Market Revenue Share, by End User (2022 and 2028)

11.3      Doctor Office

11.3.1     Overview

11.3.2     Doctor Office Market Revenue and Forecast to 2028 (US$ Million)

11.4      Community Health Clinics

11.4.1     Overview

11.4.2     Community Health Clinics Market Revenue and Forecast to 2028 (US$ Million)

11.5      School-based Health Centers

11.5.1     Overview

11.5.2     School-based Health Centers Market Revenue and Forecast to 2028 (US$ Million)

11.6      Health Departments

11.6.1     Overview

11.6.2     Health Departments Market Revenue and Forecast to 2028 (US$ Million)

11.7      Hospitals

11.7.1     Overview

11.7.2     Hospitals Market Revenue and Forecast to 2028 (US$ Million)

11.8      Others

11.8.1     Overview

11.8.2     Others Market Revenue and Forecast to 2028 (US$ Million)

12.        North America Human Papillomavirus (HPV) Vaccine Market - Country Analysis

12.1      North America: Human Papillomavirus (HPV) Vaccine Market

12.1.1     Overview

12.1.2     North America: Human Papillomavirus (HPV) Vaccine Market, by Country, 2022 & 2028 (%)

12.1.2.1       US: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

12.1.2.1.1       Overview

12.1.2.1.2       US: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

12.1.2.1.3       US: Human Papillomavirus (HPV) Vaccine Market, by Type, 2019–2028 (US$ Million)

12.1.2.1.4       US: Human Papillomavirus (HPV) Vaccine Market, by Dosage, 2019–2028 (US$ Million)

12.1.2.1.5       US: Human Papillomavirus (HPV) Vaccine Market, by Age, 2019–2028 (US$ Million)

12.1.2.1.6       US: Human Papillomavirus (HPV) Vaccine Market, by Application, 2019–2028 (US$ Million)

12.1.2.1.7       US: Human Papillomavirus (HPV) Vaccine Market, by End User, 2019–2028 (US$ Million)

12.1.2.2       Canada: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

12.1.2.2.1       Overview

12.1.2.2.2       Canada: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

12.1.2.2.3       Canada: Human Papillomavirus (HPV) Vaccine Market, by Type, 2019–2028 (US$ Million)

12.1.2.2.4       Canada: Human Papillomavirus (HPV) Vaccine Market, by Dosage, 2019–2028 (US$ Million)

12.1.2.2.5       Canada: Human Papillomavirus (HPV) Vaccine Market, by Age, 2019–2028 (US$ Million)

12.1.2.2.6       Canada: Human Papillomavirus (HPV) Vaccine Market, by Application, 2019–2028 (US$ Million)

12.1.2.2.7       Canada: Human Papillomavirus (HPV) Vaccine Market, by End User, 2019–2028 (US$ Million)

12.1.2.3       Mexico: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

12.1.2.3.1       Overview

12.1.2.3.2       Mexico: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

12.1.2.3.3       Mexico: Human Papillomavirus (HPV) Vaccine Market, by Type, 2019–2028 (US$ Million)

12.1.2.3.4       Mexico: Human Papillomavirus (HPV) Vaccine Market, by Dosage, 2019–2028 (US$ Million)

12.1.2.3.5       Mexico: Human Papillomavirus (HPV) Vaccine Market, by Age, 2019–2028 (US$ Million)

12.1.2.3.6       Mexico: Human Papillomavirus (HPV) Vaccine Market, by Application, 2019–2028 (US$ Million)

12.1.2.3.7       Mexico: Human Papillomavirus (HPV) Vaccine Market, by End User, 2019–2028 (US$ Million)

13.        Industry Landscape

13.1      Overview

13.2      Inorganic Growth Strategies

13.2.1     Overview

13.3      Organic Growth Strategies

13.3.1     Overview

14.        Company Profiles

14.1      Merck & Co., Inc.

14.1.1     Key Facts

14.1.2     Business Description

14.1.3     Products and Services

14.1.4     Financial Overview

14.1.5     SWOT Analysis

14.1.6     Key Developments

14.2      GlaxoSmithKline plc.

14.2.1     Key Facts

14.2.2     Business Description

14.2.3     Products and Services

14.2.4     Financial Overview

14.2.5     SWOT Analysis

14.2.6     Key Developments

14.3      Serum Institute of India Pvt. Ltd

14.3.1     Key Facts

14.3.2     Business Description

14.3.3     Products and Services

14.3.4     Financial Overview

14.3.5     SWOT Analysis

14.3.6     Key Developments

14.4      Walvax Biotechnology Co., Ltd.

14.4.1     Key Facts

14.4.2     Business Description

14.4.3     Products and Services

14.4.4     Financial Overview

14.4.5     SWOT Analysis

14.4.6     Key Developments

14.5      Inovio Pharmaceuticals

14.5.1     Key Facts

14.5.2     Business Description

14.5.3     Products and Services

14.5.4     Financial Overview

14.5.5     SWOT Analysis

14.5.6     Key Developments

14.6      Vaccitech

14.6.1     Key Facts

14.6.2     Business Description

14.6.3     Products and Services

14.6.4     Financial Overview

14.6.5     SWOT Analysis

14.6.6     Key Developments

14.7      ChengDu Institute of Biological Products Co., Ltd.

14.7.1     Key Facts

14.7.2     Business Description

14.7.3     Products and Services

14.7.4     Financial Overview

14.7.5     SWOT Analysis

14.7.6     Key Developments

14.8      Sanofi

14.8.1     Key Facts

14.8.2     Business Description

14.8.3     Products and Services

14.8.4     Financial Overview

14.8.5     SWOT Analysis

14.8.6     Key Developments

14.9      R-Pharm

14.9.1     Key Facts

14.9.2     Business Description

14.9.3     Products and Services

14.9.4     Financial Overview

14.9.5     SWOT Analysis

14.9.6     Key Developments

15.        Appendix

15.1      About The Insight Partners

15.2      Glossary of Terms

LIST OF TABLES

Table 1.             North America Human Papillomavirus (HPV) Vaccine Market, Revenue and Forecast, 2019–2028 (US$ Mn)

Table 2.             US Human Papillomavirus (HPV) Vaccine Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 3.             US Human Papillomavirus (HPV) Vaccine Market, by Dosage– Revenue and Forecast to 2028 (US$ Million)

Table 4.             US Human Papillomavirus (HPV) Vaccine Market, by Age– Revenue and Forecast to 2028 (US$ Million)

Table 5.             US Human Papillomavirus (HPV) Vaccine Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 6.             US Human Papillomavirus (HPV) Vaccine Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 7.             Canada: Human Papillomavirus (HPV) Vaccine Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 8.             Canada Human Papillomavirus (HPV) Vaccine Market, by Dosage– Revenue and Forecast to 2028 (US$ Million)

Table 9.             Canada Human Papillomavirus (HPV) Vaccine Market, by Age– Revenue and Forecast to 2028 (US$ Million)

Table 10.          Canada Human Papillomavirus (HPV) Vaccine Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 11.          Canada Human Papillomavirus (HPV) Vaccine Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 12.          Mexico: Human Papillomavirus (HPV) Vaccine Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 13.          Mexico Human Papillomavirus (HPV) Vaccine Market, by Dosage– Revenue and Forecast to 2028 (US$ Million)

Table 14.          Mexico Human Papillomavirus (HPV) Vaccine Market, by Age– Revenue and Forecast to 2028 (US$ Million)

Table 15.          Mexico Human Papillomavirus (HPV) Vaccine Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 16.          Mexico Human Papillomavirus (HPV) Vaccine Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 17.          Recent Inorganic Growth Strategies

Table 18.          Recent Organic Growth Strategies

Table 19.          Glossary of Terms

LIST OF FIGURES

Figure 1.           North America Human Papillomavirus (HPV) Vaccines Market Segmentation

Figure 2.           North America Human Papillomavirus (HPV) Vaccines Market, By Country

Figure 3.           North America Human Papillomavirus (HPV) Vaccine Market Overview

Figure 4.           North America Human Papillomavirus (HPV) Vaccines Market, By Type

Figure 5.           North America Human Papillomavirus (HPV) Vaccines Market, By Country

Figure 6.           North America: PEST Analysis

Figure 7.           Experts Opinion

Figure 8.           North America Human Papillomavirus (HPV) Vaccines Market Impact Analysis of Driver and Restraints

Figure 9.           North America Human Papillomavirus (HPV) Vaccine Market– Revenue Forecast and Analysis

Figure 10.        By Type: Market Analysis and Forecast 2022 and 2028 (%)

Figure 11.        North America 9-valent HPV vaccine Market Revenue and Forecast to 2028 (US$ Million)

Figure 12.        North America Quadrivalent HPV vaccine Market Revenue and Forecast to 2028 (US$ Million)

Figure 13.        North America Bivalent HPV Vaccine Market Revenue and Forecast to 2028 (US$ Million)

Figure 14.        North America Human Papillomavirus (HPV) Vaccine Market Revenue Share, by Dosage (2022 and 2028)

Figure 15.        North America 2 Dose: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.        North America 3 Dose: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.        North America Human Papillomavirus (HPV) Vaccine Market Revenue Share, by Age (2022 and 2028)

Figure 18.        North America 9 to 14 Years: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.        North America 15 to 45 Years: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20.        North America Human Papillomavirus (HPV) Vaccine Market Revenue Share, by Application (2022 and 2028)

Figure 21.        North America HPV-attributable Cancer: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.        North America Genital Warts: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23.        North America Human Papillomavirus (HPV) Vaccine Market Revenue Share, by End User (2022 and 2028)

Figure 24.        North America Doctor Office Market Revenue and Forecast to 2028 (US$ Million)

Figure 25.        North America Community Health Clinics Market Revenue and Forecast to 2028 (US$ Million)

Figure 26.        North America School-based Health Centers Market Revenue and Forecast to 2028 (US$ Million)

Figure 27.        North America Health Departments Market Revenue and Forecast to 2028 (US$ Million)

Figure 28.        North America Hospitals Market Revenue and Forecast to 2028 (US$ Million)

Figure 29.        North America Others Market Revenue and Forecast to 2028 (US$ Million)

Figure 30.        North America: Human Papillomavirus (HPV) Vaccine Market, by Key Country – Revenue (2022) (US$ Million)

Figure 31.        North America: Human Papillomavirus (HPV) Vaccine Market, by Country, 2022 & 2028 (%)

Figure 32.        US: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

Figure 33.        Canada: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

Figure 34.        Mexico: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)